Lates News

According to AI Express News, Huayuan Securities released a research report on April 19 giving a "buy" rating to Mindray Medical (300760.SZ). The reasons for the rating mainly include: 1) steady growth of overseas business and continuous improvement of production line competitiveness; 2) slight adjustment of production line gross margin, with net profit margin under pressure in the short term. (Daily Economic News)